SUBTHERAPEUTIC LEVELS OF INFLIXIMAB AND ADALIMUMAB ARE ASSOCIATED WITH INCREASED DISEASE ACTIVITY IN PATIENTS WITH CROHN?S DISEASE

Arne Carlsen  1     Kjetil Isaksen  1     Kristian Leitao  2     Anne Kristine Hetta  1     Lars Karlsen  3     Roald Omdal     Lars Aabakken     Nils Bolstad     David Warren     Knut E.A. Lundin     Tore Grimstad    
1 Stavanger University Hospital, Department of Medicine, Stavanger, Norway
2 Stavanger University Hospital, Department Of Gastroenterology, Stavanger, Norway
3 Stavanger University Hospital, De

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing